In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2”)-Id gene
Authors:
- 1 August 2000
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 37 (4) , 297-299
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci [In Process Citation]Journal of Antimicrobial Chemotherapy, 1998
- In vitro susceptibility and molecular analysis of gentamicin-resistant enterococciDiagnostic Microbiology and Infectious Disease, 1998
- A New High-Level Gentamicin Resistance Gene, aph(2")-Id , in Enterococcus sppAntimicrobial Agents and Chemotherapy, 1998
- Enzymatic 2'-N-Acetylation of Arbekacin and Antibiotic Activity of Its Product.The Journal of Antibiotics, 1996
- Structures of enzymatically modified products of arbekacin by methicillin-resistant Staphylococcus aureus.The Journal of Antibiotics, 1993
- Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistanceAntimicrobial Agents and Chemotherapy, 1993
- Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococciAntimicrobial Agents and Chemotherapy, 1990
- Pharmacokinetics of Sulbactam/Ampicillin in Humans: A ReviewClinical Infectious Diseases, 1986
- Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activitiesJournal of Bacteriology, 1986
- Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5''-aminoglycoside phosphotransferase type IIIGene, 1983